CJ Bioscience to acquire remaining EzBiome, Inc. (US) shares for ₩7.6bn
CJ Bioscience filed to acquire 185,667 shares of EzBiome, Inc. (US) for ₩7.6bn, equal to 14.1% of its equity, which would raise its stake to 100.0%. The expected date is Nov 23, 2026, and the stated purpose is repayment of subsidiary borrowings and liquidation. By our calculation, the deal amount is 204.5% of FY2025 revenue.
Key facts
| Target company | EzBiome, Inc. (US) |
|---|---|
| Shares | 185,667 shares |
| Deal amount | ₩7.6bn |
| % of equity | 14.1% |
| Stake after | 100.0% |
| Purpose | Repayment of subsidiary borrowings and liquidation |
| Expected date | Nov 23, 2026 |
Comparison
| Amount as % of FY2025 revenue (calculated) | 204.5% |
|---|---|
| Revenue 2025 | ₩3.7bn |
| Revenue 2024 | ₩3.5bn |
| Revenue 2023 | ₩5.6bn |
Context
Q3 2026 revenue was ₩863m, up 16.9% year on year, and the operating loss for Q3 2026 was ₩4.9bn.
Source: DART (Financial Supervisory Service) · Original filing on DART ↗